Objective This present study aimed to investigate the relationship between working hours and anxiety/depression mood of medical staff in China during COVID-19 epidemic. Methods The cross-sectional interview study was conducted during the period between February 14th and February 29th, 2020. A total of 291 Chinese medical professionals were recruited from 4 cities and participated in the study. Results In 291 participants, 116 (40.0%) medical staff experienced anxiety and 151 (51.8%) underwent depressed mood. In male, the level of GAD-7 and PHQ-9 scores increased with the elevation of working hours per day (WHPD) (beta=0.579, p=0.003 and beta=0.943; p=0.001) respectively. In female, nonlinear relationship mode was demonstrated. The levels of GAD-7 and PHQ-9 scores increased with the elevation of working hours when it was above 5 hours (beta=1.432; p<0.001 and beta=1.177; p0.05). Conclusion During the COVID-19 epidemic, we found a strong correlation between the psychological mood and WHPD. The correlation followed different modes in male and female medical workers. Enforcing an upper time limit of WHPD may help decrease the risk of pandemic-related psychological problems in medical workers.
Partial psychotic disorders such as autoimmune psychosis do not respond adequately to conventional antipsychotic drugs or psychotherapy. Autoimmune psychosis presents with isolated psychiatric symptoms, responds to immunotherapy, and differs from typical autoimmune encephalitis. Previous study has proposed an approach to identifying autoimmune psychosis, however, further research remains necessary to enhance our understanding of this condition. We describe 3 patients presenting with acute or recurrent psychiatric symptoms (patient 1, 2 and 3), accompanied by cognitive impairment (patient 1), autonomic dysfunction (patient 2), and/or abnormal electroencephalogram (patient 1). Brain magnetic resonance imaging results and autoimmune antibodies in cerebrospinal fluid testing were normal. However, the cerebrospinal fluid-restricted oligoclonal bands were detected in patient 1 and patient 2, while patient 3 showed positive tissue-based assay results in cerebrospinal fluid. Combined steroid therapy could enhance the limited improvement in patient 1, who had been treated with blonanserin, valproate and modified electroconvulsive therapy, and could also prevent symptom recurrence in patient 2, who received antipsychotic treatment. In contrast, in the absence of combined steroid therapy, patient 3 had only partial improvement with risperidone and valproate. Cerebrospinal fluid-restricted oligoclonal bands and tissue-based assay in cerebrospinal fluid could both provide sufficient evidence for autoimmune psychosis in the absence of clear neurological symptoms. For patients with mild psychiatric symptoms, low-dose of steroids may also be a treatment option. Autoimmune psychosis should be considered when antipsychotic drugs or modified electroconvulsive therapy are not effective in patients with psychotic disorders.
Introduction: Magnetic seizure therapy (MST) is an emerging convulsive treatment for treatment-resistant depression (TRD) with efficacy comparable to electroconvulsive therapy and superior cognitive safety. However, its neurophysiological mechanisms—particularly those underlying conflict monitoring and response inhibition—remain unclear. Frontal midline theta-band activity indexes anterior cingulate–prefrontal cognitive-control activity and may reflect inefficient neural processing in depression. Methods: In this open-label, single-arm trial, 19 patients with TRD (16 female; mean age 20.89 ± 8.16 years; 10 of the 19 participants were minors) received 6–12 MST sessions using 100-Hz double-cone coil stimulation targeting bilateral F3/F4 frontal regions. Clinical assessments, including the 24-item Hamilton Depression Rating Scale (HAMD-24), Hamilton Anxiety Rating Scale (HAMA), Montgomery-Åsberg Depression Rating Scale (MADRS), and 64-channel Go/Nogo task-based electroencephalography (EEG), were performed before and after treatment. EEG outcome measures included event-related potentials (N2/P3), time-frequency power (theta/beta), microstate dynamics, and theta–beta cross-frequency coupling. Results: Following MST, patients showed significant reductions in depressive symptoms (HAMD: 40.53 ± 10.25 to 22.53 ± 11.21; MADRS: 35.68 ± 8.84 to 20.68 ± 11.12). Response rates ranged from 42.1% to 57.9%. Behavioral data could not be formally analyzed due to incomplete data storage. At an uncorrected threshold, total Nogo-related theta-band activity (4–7 Hz) at Fz and FCz was lower after treatment; however, these effects did not survive FDR correction. ERP amplitudes did not change significantly. Exploratory microstate analysis showed nominal changes in Map4 AUC during Go processing and Map2 duration during Nogo processing; none survived FDR correction. These parameters should not be interpreted as reflecting changes in neural activation or inhibitory preparation. No significant changes were observed in theta–beta cross-frequency coupling or Go-condition theta power. Discussion: These preliminary findings suggest that MST was associated with short-term symptom improvement and lower total Nogo-related theta-band activity at an uncorrected threshold. Because no control group, complete behavioral data, normative comparison, Time × Condition interaction, or EEG-clinical association was available, these findings cannot establish causal mechanisms, condition specificity, improved neural efficiency, or biomarker utility. Replication in adequately powered controlled studies with complete behavioral and longitudinal clinical measures is required.